Here’s what you should know.
1. Both Mylan’s EpiPen and Impax’s Adrenaclick auto injector were placed on the drug shortages list.
2. Both companies are facing manufacturer delays.
3. Mylan released a statement saying it is receiving continuous supply from its manufacturer.
4. Pfizer, owner of the manufacturer, said, “Pfizer takes very seriously the importance of EpiPen to everyone who needs it, and we are working tirelessly to increase production as rapidly as possible.” Pfizer has increased its EpiPen production over the last few months.
More articles on supply chain:
California bill allowing government to determine healthcare pricing met with fierce opposition
Common deficiencies cited by AAAASF and how to fix them — Every OR must be equipped with an AED or standard defibrillator
Total joints in ASCs: 4 common questions answered
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
